D M Barends

Results of a market surveillance study in The Netherlands on break-mark tablets.

H W Frijlink, D M Barends, D W Groot, 2006, Pharmeuropa scientific notes.

Development of an in vivo test procedure for the ease of breaking of scored tablets.

H W Frijlink, D M Barends, D W Groot, 2005, Pharmeuropa scientific notes.

Biowaiver monographs for immediate release solid oral dosage forms: ranitidine hydrochloride.

D M Barends, H E Junginger, D. Barends, 2005, Journal of pharmaceutical sciences.

In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.

D M Barends, M Olling, D. Barends, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Consistency of FMEA used in the validation of analytical procedures.

M Weda, D M Barends, D de Kaste, 2011, Journal of pharmaceutical and biomedical analysis.

Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy.

R Hoogerbrugge, D M Barends, D de Kaste, 2006, Journal of pharmaceutical and biomedical analysis.

Risk analysis by FMEA as an element of analytical validation.

D M Barends, D de Kaste, D. Barends, 2009, Journal of pharmaceutical and biomedical analysis.

Biowaiver monographs for immediate release solid oral dosage forms: furosemide.

D M Barends, H E Junginger, D. Barends, 2010, Journal of pharmaceutical sciences.

Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.

G L Amidon, D M Barends, M Olling, 2004, Journal of pharmaceutical sciences.

Breaking of scored tablets: a review.

H W Frijlink, D M Barends, D. Barends, 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.